Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex Extension Study for Uterine Fibroids
NCT02811159Phase 2Terminated
- Sponsor
- Repros Therapeutics Inc.
- Start
- Jul 2016
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of telapristone in Uterine Fibroids (UF), sponsored by Repros Therapeutics Inc.. Started Jul 2016; status: terminated.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02811159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02811159.